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Obstructive sleep apnea- hypopnea syndrome (OSAHS) is a common 
disease which causes a tendency to fall a daytime sleep, cognitive impair-
ment and decreased a quality of life. Metabolic syndrome (MS) is de¿ ned by 
the association of morphological, physiological and biochemical abnormalities 
predisposing the affected individual to very high risk of atherosclerosis and 
cardiovascular pathology. Microparticles (MPs) are small membrane vesicles, 
released into the extracellular space following to cell activation or apoptosis. 
Although OSAHS and MS patients display endothelial dysfunction, circula-
ting levels of MPs are either not modi¿ ed or increased, respectively. Here, 
we evaluated the effects of the combination of both intermittent hypoxia (IH) 
and obesity in mice. For this, mice were divided in four groups: (i) control 
(normoxia and normal diet), (ii) high- fat diet (HFD, 42% calories from fat 
for 8 weeks), (iii) IH (for 2 weeks, 8 hours of IH/day, 1 stimulus by 30- 60 
seconds, 60- 120 desaturation/hour) and (iv) group receiving both HFD and 
IH (for 8 weeks, the last two receiving IH). We showed that although HFD 
did not induce changes in the weight of the mice, it was able to induce early- 
onset obesity as reÀ ecting by the increase of adipose tissue weight. This was 
accompanied by an increased rate of macrophage and erythrocyte MPs as well 
as a decrease in the endothelium- dependent relaxation evoked by acetylcho-
line suggesting that HFD induces an endothelial dysfunction. On the other 
hand, exposure to IH induced an increase in the rate of leukocyte, macro-
phage and red blood cell MPs, without changes in endothelium- dependent 
relaxation. Finally, animals from the group with both treatments displayed a 
similar pro¿ le of MPs as those treated with IH alone. In addition, IH pre-
vented both fat deposition and endothelial dysfunction induced by HFD alone. 
These results suggest that IH might protect vascular function in HFD models 
under these experimental conditions.
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Rational: Hemolytic disorders like sickle cell disease are linked to the 
occurrence plasma heme, called ‘free’ heme. We hypothesized that free heme 
associates with cell fragments called microparticules (MP) that express phos-
phatidylserine (PS) at their surface. We thought that free heme associated to 
MP may prove particularly toxic for vascular’endothelium. 
Material and Methods: Sickle cell and healthy erythrocytes were sepa-
rated from platelet- free plasma (PFP) by Ficoll gradients centrifugation. We 
puri¿ ed different types of MP : 1/ MP from PPP, 2/MP shed by erythrocytes 
in vitro, 3/synthetic MP generated from a PS:Phosphatidylcholine mix, loaded 
with heme in the presence of calcium. We analyzed their contents in heme 
by spectrophotometry (540 nm) and Western blot, and characterized MP par 
FACS after labeling with annexin- V. We compared the effects of the puri-
¿ ed MP on endothelial monolayers in vitro (HUVEC) to those of heme in 
solution: Radical oxygen species (ROS) production with several À uorescent 
probes; Apoptosis by FACS and À uorescent microscopy. 
Results: Heme- loaded erythrocyte MP induced excessive ROS production, 
when contacting the endothelium. The effects were reproduced, in part, by 
synthetic MP arti¿ cially loaded with heme. These effects exceeded those of 
heme alone at similar concentrations. ROS production was inhibited by satu-
rating MP PS with annexin- V, or by pre- treatment with hemopexin. Sickle 
cell MP differed from healthy MP in size, PS expression, and contained more 
heme and hemoglobin. ROS induced by sickle cell MP were released by 
HUVEC and not MP and production was blocked by pharmacological targe-
ting of endothelial NADPH oxydase and PKC. In vitro, ROS induced endo-
thelial apoptosis. The toxic effects of heme- loaded MP could be abrogated by 
hemopexin, a plasma protein that chelates free heme. 
Discussion: We concluded that sickle cell MP are loaded with heme and 
stimulate endothelial ROS production through NADPH oxidase, and induce 
endothelial apoptosis in a more ef¿ cient fashion than heme alone. Our results 
show that erythrocyte degradation products can directly bridge hemolysis to 
vascular injury and could participate to vasculopathy in hemolytic syndromes 
like sickle cell disease.
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Background: Patients with sickle cell disease suffer from painful vaso- 
occlusive crises. These crises are associated with disseminated vaso- 
occlusions, raised levels of circulating erythrocyte microparticles as well as 
thrombospondin- 1 (TSP1). Microparticules (MP) are submicron membrane 
vesicles shed by compromised or activated cells. We hypothesized that TSP1 
mediates the shedding of erythrocyte MP and participates in vaso- occlusions. 
Methods and Results: We injected TSP1 to transgenic SAD mice with 
sickle cell disease, sensitive to renal vaso- occlusions. We characterized cir-
culating MP by FACS after phosphatidylserine labeling. TSP1 injection 
strongly stimulated MP levels (+260%) and initiated renal vaso- occlusions 
within 5 minutes, without impacting systemic parameters (heart rate, cardiac 
output). This was consistent with increased local vascular resistance. In 
vitro, TSP1 triggered a rapid conversion of puri¿ ed erythrocytes into echi-
nocytes carrying long and apparently fragile spicules. This was followed by 
MP shedding. These modi¿ cations of erythrocyte phenotype and MP shed-
ding were recapitulated by peptides derived from TSP1 carboxyterminus. We 
puri¿ ed the MP shed by erythrocytes in vitro, and administered them back 
into SAD mice. Erythrocyte MP triggered immediate renal vaso- occlusions, 
similar to those induced by TSP1. In vitro, puri¿ ed erythrocyte MP triggered 
the production of radical oxygen species by endothelial monolayers, favored 
erythrocyte adhesion to them and induced endothelial apoptosis. Puri¿ ed 
erythrocyte MP also compromised acetylcholine- dependent vasodilation 
in perfused microvessels. These effects of MP were inhibited by saturating 
surface phosphatidylserine with annexin- V, or with inhibitors of endothelial 
ROS production. 
Conclusions: We conclude that TSP1 can trigger the production of micro-
particles by erythrocytes in sickle cell disease. Second, our data reveal that 
erythrocyte MP can induce endothelial injury, and this mechanism facilitates 
the occurrence of vaso- occlusive crises in mice. Therefore, our work sup-
ports a novel concept that toxic erythrocyte microparticles constitute a direct 
connection between sickle cell anemia and vascular disease.
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Background: Remote ischemic conditioning (RCond) induced by short 
periods of ischemia and reperfusion of an organ or tissue before myocardial 
reperfusion is a powerful and attractive strategy of cardioprotection in the 
context of acute myocardial infarction. Nonetheless, its mechanism remains 
unknown. A humoral factor appears to be involved, although its identity is 
currently unknown. We hypothesized that the circulating microparticles (MPs) 
are the link between the remote tissue and the heart. 
Methods: MPs from rats and healthy human undergoing RCond were 
characterized. In rats, RCond was induced by 10min of limb ischemia. In 
humans, RCond was induced by three cycles of 5min inÀ ation and 5 min 
deÀ ation of a blood- pressure cuff. In the second part of the study, rats 
underwent 40 min myocardial ischemia followed by 2 hours of reperfu-
sion. Infarct size was measured and compared among three groups of rats: 
(1) myocardial infarction alone (MI) (n=6); (2) MI+RCond started 20min 
after coronary ligation (n=6); (3) MI+injection of RCond- derived rat MPs 
(MI+MPs) (n=5).
Results: MPs from endothelial cells (CD54+ and CD146+ for rats and 
humans, respectively) and procoagulant MPs (Annexin V+) markedly 
increased after RCond, both in rats and humans. RCond reduced infarct size 
(24.4±5.9% in MI+RCond vs. 54.6±4.7% in MI alone, P<0.01). Infarct size 
did not decrease in MI+MPs compared to MI alone (50.2±6.4% vs. 54.6±4.7%, 
not signi¿ cantly different).
Conclusion: RCond increased endothelium- derived and procoagulant MPs 
in both rats and humans. However, MP release did not appear to be a biolo-
gical vector of RCond in our model.
